FDA Approved Products

Application #TypeSponsorNotesProduct #Drug NameFormStrengthActive IngredientApproval DateMarketing StatusReference Standard
211617NDAESPERION THERAPS INC001NEXLIZETTABLET;ORAL180MG;10MGBEMPEDOIC ACID; EZETIMIBE2020-02-26PrescriptionYes
211616NDAESPERION THERAPS INC001NEXLETOLTABLET;ORAL180MGBEMPEDOIC ACID2020-02-21PrescriptionYes